Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease.

MLA

Li, Xuan, et al. “Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease.” EBioMedicine, vol. 19, May 2017, pp. 139–45. EBSCOhost, https://doi.org/10.1016/j.ebiom.2017.04.020.

APA

Li, X., Obeidat, M., Zhou, G., Leung, J. M., Tashkin, D., Wise, R., Connett, J., Joubert, P., Bossé, Y., van den Berge, M., Brandsma, C.-A., Nickle, D. C., Hao, K., Paré, P. D., & Sin, D. D. (2017). Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease. EBioMedicine, 19, 139–145. https://doi.org/10.1016/j.ebiom.2017.04.020

Chicago

Li, Xuan, Ma’en Obeidat, Guohai Zhou, Janice M Leung, Donald Tashkin, Robert Wise, John Connett, et al. 2017. “Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease.” EBioMedicine 19 (May): 139–45. doi:10.1016/j.ebiom.2017.04.020.